Wegovy SUS: How Patients Can Request It Today and What to Expect

If you have already read about what was proposed for Wegovy SUS, the next question is probably practical: can I request it today, and what do I need to bring? This post starts where the proposal coverage stops. For a parallel walkthrough, the access guide on OzemBlog covers similar ground. Treat everything here as general orientation, because the official text always has the final word.

Approved, published, and actually available are three different things

A medicine can be recommended for the SUS, then formally incorporated, and still take months to reach a patient. Each stage is separate. Conitec, the technical body that evaluates new technologies for the public system, issues a recommendation. The formal decision comes later, and it is published as an ordinance in the Diário Oficial da União, which you can search through the Imprensa Nacional portal. Only after that does a state or municipality set up supply and dispensing.

This article does not list a consultation date or process number, since those change as the process moves. Check the Conitec page for the current status of the process, then search the Diário Oficial to see whether an ordinance has been published. A recommendation alone does not mean you can walk into a pharmacy and pick up a box.

How a medicine enters the SUS

Law 12.401/2011 created Conitec and set the framework for how the SUS decides whether to incorporate a technology. After Conitec makes its recommendation, the Ministry of Health decides. If the answer is yes, the relevant Protocolo Clínico e Diretriz Terapêutica, or PCDT, usually needs to be updated. The PCDT defines who qualifies, which tests come first, and what the treatment path looks like.

Even after a decision, availability depends on agreements between the federal government, states, and municipalities. That is why the experience can differ from one region to another. One state may already have a working flow, while another is still organizing its pharmacies and forms.

The law also sets deadlines for decisions and allows extensions in certain cases. The exact numbers are in the law text and in Conitec's own rules, so read them on the official site instead of trusting a secondhand summary.

Who can join the path: criteria and documents

Early proposals and final decisions often differ. A proposal may describe a BMI range, certain comorbidities, and a history of non-drug treatment. The final PCDT is the version that counts, so read its actual criteria. Ask your doctor which version applies to you and whether any part of it changed recently.

In general, expect to bring the following:

• A prescription written in the format your state or municipality accepts
• A medical report with the diagnosis, the CID-10 code, and your BMI value with the measurement date
• Exams that document any related conditions, such as type 2 diabetes or hypertension
• A written record of earlier attempts at diet and physical activity

In Brazilian medical documents, obesity is usually coded as CID-10 E66, and body mass index is recorded with code Z68, which is used together with the measured value. Ask your doctor to write both the diagnosis and the BMI in the report, along with the date. Vague notes slow the process down. The official CID-10 tables are available on the DATASUS website.

Before the appointment, write down your weight history, the treatments you have tried, and the dates when they happened. The OzemBlog checklist for doctor visits can help you organize these details so nothing gets forgotten. Also confirm with the health unit which prescription form is accepted and how long it stays valid, because those rules can change.

Step by step: from the health unit to the pharmacy window

The usual route begins in primary care at the Unidade Básica de Saúde. The doctor there evaluates you and, if the criteria seem to fit, refers you to specialized care. The specialist confirms eligibility, orders any missing tests, and submits the request through the system your health office uses. If approved, the medicine is dispensed at a pharmacy designated by the state or municipality.

Ask whether the medicine falls under the Componente Especializado da Assistência Farmacêutica, or CEAF, which is the component that often handles specialized drugs. The protocol and your local secretariat confirm which unit dispenses it, how often you need to return for follow-up, and what forms come with each visit. Do not assume these details from another state's experience.

Pickup locations vary, so check the official list of pharmacies on your state or municipal health secretariat website. Confirm the flow with the staff at your unit as well. On the day you file, ask for a protocol or request number in writing, and keep it with your documents. If the process stalls, that number lets you follow up without starting over.

When the request is denied or delayed

A denial is not always the final answer. Start by asking for the reason in writing. A formal justification shows which criterion was not met, and that document is the foundation of any administrative appeal. Many health offices have an internal appeal process, so check your secretariat's rules before anything else.

If the administrative route fails, the Defensoria Pública may help. The Federal Constitution assigns it the role of providing legal assistance to people who cannot afford a private lawyer. Going to court is also possible, but each case depends on its facts, medical evidence, and local rules. Get legal advice before you file.

The Supreme Federal Court, or STF, has issued repercussion-general theses on drug supply through the SUS. Two of the most cited are Tema 6, on high-cost medicines, and Tema 500, on medicines without Anvisa registration. Their conditions are detailed and have been discussed over time, so a short summary can mislead. Read the official thesis and confirm its theme number on the STF portal, and ask a lawyer how it applies to your situation.

While you wait, do not stop or swap your treatment on your own. Sudden changes can cause problems. Ask your doctor what interim options exist, and keep a written record of each conversation.

Buying with a prescription: plans, prices, and what to check

If you have a health plan, first check whether it covers anti-obesity medication. The ANS publishes the reference list of procedures that plans must cover, and you should read the current version. Your contract may still add rules about prior authorization, waiting periods, or specific indications, so review it too. A list entry alone does not guarantee coverage for your exact product.

Pharmacy prices are not the same as the regulated ceiling. The CMED, the Chamber of Regulation of the Medicines Market, publishes maximum prices for medicines sold in Brazil. Pharmacies can charge up to that ceiling and often charge less. Prices also change by presentation and dose, so compare the same product, strength, and number of pens. A price for one strength tells you little about another.

Before you buy, search the product in Anvisa's public medicine consultation. Match the registration number on the box with what the pharmacy hands you, and check the presentation too. OzemBlog's notes on reading price quotes explain which label details matter most, which can save you from an expensive mistake.

FAQ

Can I get Wegovy through the SUS right now?

It depends on your state or municipality and on the rules in force at the moment. Approval, publication, and actual dispensing are separate steps, so check Conitec, the Diário Oficial, and your local health secretariat before you assume anything.

Which documents should I bring to the health unit?

Bring your prescription, any medical report, exams that document related conditions, and a written record of earlier diet and exercise attempts. Ask the doctor to include the CID-10 code and your BMI with the measurement date.

What should I do if my request is denied?

Ask for the denial in writing, then check whether your health office has an internal appeal. If that fails, the Defensoria Pública or a private lawyer can explain the court route, which depends on your specific case.

Can I stop my current treatment while I wait for the SUS decision?

Not without talking to your doctor first. Stopping or switching medicines on your own can be risky. Your doctor can suggest a safer plan for the waiting period.

Sources

• Conitec, Comissão Nacional de Incorporação de Tecnologias no SUS
• Lei nº 12.401, de 28 de abril de 2011
• Constituição da República Federativa do Brasil de 1988
• Imprensa Nacional, Portal da Imprensa Nacional e Diário Oficial da União
• Anvisa, Câmara de Regulação do Mercado de Medicamentos (CMED)
• Anvisa, Consulta de Medicamentos
• ANS, O que é o Rol de Procedimentos e Eventos em Saúde
• CID-10, Classificação Estatística Internacional de Doenças, DATASUS
• STF, Repercussão Geral, Tema 6 (RE 566.471)
• STF, Repercussão Geral, Tema 500 (RE 657.718)